Whole Transcriptome Profiling for ROHHAD Syndrome
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
Recruiting
Observational Study
Childhood Obesity
Morbid Obesity
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 2 – 20
- Sex
- Any
- Study type
- Observational
- Participants needed
- 12 (estimated)
- Sponsor
- Columbia University · Other
Who this trial is looking for
This trial is looking for children diagnosed with ROHHAD syndrome. It aims to study the metabolic changes related to rapid obesity in these children.
Are You a Good Fit for This Trial?
You may be able to join if
- I have been diagnosed with ROHHAD syndrome
You may not be able to join if
- I have known genetic causes of obesity
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Rapid onset Obesity, Hypoventilation, Hypothalamic dysfunction and Autonomic Dysregulation (ROHHAD) is a syndrome named in 2007. The hallmark of the syndrome is the rapid onset obesity and dysregulation of central ventilation. There is little information about the metabolic changes that lead to the rapid onset obesity in these children. The investigators would like to study the metabolic phenotype…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Children with ROHHAD syndrome
Exclusion Criteria:
* Children with known genetic causes of obesity
Contacts